Biocon and Abbott ink deal for new R&D centre

Posted By:
Subscribe to GoodReturns

Biocon and Abbott ink deal for new R&D centre
Abbott Laboratories and Syngene Research, a unit of Biocon are collaborating to set up a research and development center for nutrition products."The Abbott Nutrition R&D Centre in India will focus on the development of science-based, affordable nutrition products for the country and enable the expansion of Abbott's nutrition product portfolio there," the company said in a statement.

More than 50 researchers and scientists will be based at the R&D centre at Biocon Park in Bangalore, which is expected to open in June, it said.

Abbott said the new R&D center will focus on the development of nutrition products for maternal and child nutrition and diabetes care.

"India is a priority market for investment, growth and innovation," said Robert Miller, Divisional Vice President, Global R&D and Scientific Affairs for Abbott Nutrition.

"With malnutrition and common chronic diseases at their highest in this region, Abbott and Syngene have a common vision and commitment to support the development of a healthier India," Kiran Mazumdar-Shaw, Founder, Chairman and Managing Director, Biocon Group said.

Abbott India shares were seen trading at Rs 1,610, up 0.06% on the BSE, while the shares of Biocon were trading lower by 0.11% at Rs 237.40 at 11.10 am IST.

Read more about: biocon, abbott, shares
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?